| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |